Royal Bank Scotland Group Plc (RBS) 4.85 $RBS Deutsche

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Royal Bank Scotland Group Plc (RBS) 4.85 $RBS

Deutsche Bank (DB) Considers Sale of $1B Shipping Loans
Zacks Equity Research - Zacks Investment Research - Thu Jul 07, 5:25PM CDT
Deutsche Bank AG (DB) is seeking to sell at least $1 billion of shipping loans amid heightened regulatory scrutiny over banks' exposure in the troubled industry
RY: 60.44 (-0.22), DB: 14.04 (-0.06), RBS: 4.85 (-0.02), CM: 75.43 (-0.22)

Foreign Money Center Banks Equities Technical Review - HSBC Holdings, UBS Group, The Royal Bank of Scotland Group, and East West Bancorp
PR Newswire - Thu Jul 07, 7:05AM CDT
On Wednesday, July 06, 2016, the NASDAQ Composite ended the trading session at 4,859.16, up 0.75%; the Dow Jones Industrial Average edged 0.44% higher, to finish at 17,918.62; and the S&P 500 closed at 2,099.73, up 0.54%. The gains were broad based as eight out of nine sectors ended the session in positive. Stock-Callers.com has initiated coverage on the following equities: HSBC Holdings PLC (NYSE: HSBC), UBS Group A.G. (NYSE: UBS), The Royal Bank of Scotland Group PLC (NYSE: RBS), and East West Bancorp Inc. (NASDAQ: EWBC). Learn more about these stocks by accessing their free notes at:
EWBC: 34.91 (-0.24), HSBC: 31.44 (-0.10), RBS: 4.85 (-0.02), UBS: 12.81 (-0.01), WTBA: 18.82 (-0.16)

Moody's Negative Outlook on U.K. Banking System Post-Brexit
Zacks Equity Research - Zacks Investment Research - Wed Jun 29, 8:01AM CDT
Moody's has changed the outlook on the ratings of 12 U.K. banks and building societies, while outlook on the U.K. banking system was changed to negative from stable in the wake of Brexit concerns.
BCS: 7.84 (-0.11), GS: 156.40 (-0.52), HSBC: 31.44 (-0.10), RBS: 4.85 (-0.02), LYG: 2.99 (-0.03), MCO: 100.43 (+0.26)

3 European Banking Stocks Down More Than 35% in 2 Days
Zacks Equity Research - Zacks Investment Research - Tue Jun 28, 3:20PM CDT
The U.K.'s decision to exit the EU will undoubtedly make matters worse for the European economy, which is already plagued by fundamental weakness.
BCS: 7.84 (-0.11), GS: 156.40 (-0.52), JPM: 62.85 (-0.35), CS: 10.88 (-0.19), DB: 14.04 (-0.06), BAC: 13.42 (-0.12), RBS: 4.85 (-0.02), LYG: 2.99 (-0.03), MS: 27.11 (-0.26)

Post Brexit UK Government Halts RBS, Lloyds Stakes Sale
Zacks Equity Research - Zacks Investment Research - Tue Jun 28, 7:35AM CDT
Triggered by economic uncertainties and stock market mayhem post Brexit, the U.K. government has halted plans to sale stakes in Lloyds Banking Group plc (LYG) and The Royal Bank of Scotland Group plc (RBS).
BMO: 64.23 (-0.10), RBS: 4.85 (-0.02), CM: 75.43 (-0.22), LYG: 2.99 (-0.03)

Downgrade Alert for Royal Bank of Scotland (RBS)
Comtex SmarTrend(R) - Tue Jun 28, 4:10AM CDT
Royal Bank of Scotland (NYSE:RBS) was downgraded from Neutral to Underweight at JP Morgan today. The stock closed yesterday at $4.69 on volume of 22.1 million shares, above average daily volume of 1.0 million. Royal Bank of Scotland Group plc, through subsidiaries, accepts deposits and offers commercial banking services. The bank offers business term loans, commercial mortgages, professional practice loans, asset finance and invoice finance loans, residential mortgages, consumer loans, credit cards, financial planning services, and life, personal lines, and income protection insurance.
RBS: 4.85 (-0.02)

Forget Financials, Buy These Consumer Staples Stocks Instead
Zacks Premium Research - Zacks Investment Research - Mon Jun 27, 7:32PM CDT
These kinds of stocks are preferable to own in times of uncertainty.
BCS: 7.84 (-0.11), JNJ: 123.27 (+0.35), JPM: 62.85 (-0.35), WMT: 73.27 (unch), BAC: 13.42 (-0.12), MO: 69.02 (+0.15), RBS: 4.85 (-0.02), LYG: 2.99 (-0.03), MS: 27.11 (-0.26)

Brexit Effect Continues, EU Banks Slammed
Afrasiab Mian - Zacks Investment Research - Mon Jun 27, 11:23AM CDT
The downward effect of Brexit on the market continued on Monday, particularly with EU banks opening at lows not seen in years.
BCS: 7.84 (-0.11), HSBC: 31.44 (-0.10), RBS: 4.85 (-0.02), LYG: 2.99 (-0.03)

Hot Stock: Royal Bank of Scotland, Shares Drop 14.5% (RBS)
Comtex SmarTrend(R) - Mon Jun 27, 8:50AM CDT
Royal Bank of Scotland (NYSE:RBS) is one of today's worst performing low-priced stocks, down 14.5% to $4.65 on 4.8x average daily volume. Royal Bank of Scotland has traded 4.8 million shares thus far today, vs. average volume of 1.0 million shares per day. The stock has underperformed the Dow (-14.5% to the Dow's -1.2%) and underperformed the S&P 500 (-14.5% to the S&P's -1.2%) during today's trading.
RBS: 4.85 (-0.02)

Brexit Fallout: Collapse without Hysteria
Mark Vickery - Zacks Investment Research - Mon Jun 27, 8:46AM CDT
The silver lining here might just be this most orderly of fall-outs since the Brexit decision was made.
BCS: 7.84 (-0.11), CS: 10.88 (-0.19), DB: 14.04 (-0.06), RBS: 4.85 (-0.02)

How Does Brexit Affect Britain's Economic Future?
Afrasiab Mian - Zacks Investment Research - Fri Jun 24, 2:46PM CDT
In news that shocked the market, the U.K. voted to leave the EU by a slim margin of 2%. The result of the historic vote has mixed reactions globally, as well as many deeper ramifications that must be considered.
BCS: 7.84 (-0.11), GS: 156.40 (-0.52), JPM: 62.85 (-0.35), C: 43.21 (-0.23), HSBC: 31.44 (-0.10), RBS: 4.85 (-0.02), LYG: 2.99 (-0.03)

Brexit Repercussions Hit UK-Exposed Banks, Tank Share Prices
Adam Clark - Zacks Investment Research - Fri Jun 24, 2:31PM CDT
After yesterday's decision from Britain to leave the European Union, global markets and investors are facing a great uncertainty, and so too is the banking Sector. Here are a few of the banking stocks taking a hit today.
BCS: 7.84 (-0.11), JPM: 62.85 (-0.35), DB: 14.04 (-0.06), RBS: 4.85 (-0.02)

After Yesterday's Rally of 2.46% Shares Could Potentially Pullback
Comtex SmarTrend(R) - Wed Jun 22, 2:00PM CDT
Royal Bank of Scotland (NYSE:RBS) traded in a range yesterday that spanned from a low of $7.24 to a high of $7.35. Yesterday, the shares gained 2.5%, which took the trading range above the 3-day high of $7.20 on volume of 3.5 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
RBS: 4.85 (-0.02)

RBS Plans 900 Layoffs as Cost Cutting Initiatives Continue
Zacks Equity Research - Zacks Investment Research - Wed Jun 22, 6:45AM CDT
The Royal Bank of Scotland Group plc (RBS) is likely to cut another 900 jobs as it continues with its aggressive cost cutting moves.
BCS: 7.84 (-0.11), HSBC: 31.44 (-0.10), RBS: 4.85 (-0.02), LYG: 2.99 (-0.03)

To Bet Against Brexit, Buy These 3 British Banking Stocks
Maher Syed - Zacks Investment Research - Tue Jun 21, 2:10PM CDT
You could wager on the vote itself, but this is a more prudent way to bet against Brexit.
BCS: 7.84 (-0.11), RBS: 4.85 (-0.02), LYG: 2.99 (-0.03)

Brexit: Britain's Newest Rollercoaster Ride
Afrasiab Mian - Zacks Investment Research - Mon Jun 20, 2:47PM CDT
Monday opened with a more bullish market due to polls from Britain showing an increase in support for remaining in the EU rather than exiting under Brexit.
BCS: 7.84 (-0.11), RBS: 4.85 (-0.02), LYG: 2.99 (-0.03)

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Alibaba Lawsuit Deadline Puts Disclosure Risk in Focus

Updated Category News Views 180

A calendar deadline is doing more work than any earnings headline for Alibaba shareholders this week. A securities class action notice says investors who bought or acquired Alibaba Group Holding Limited securities between May 23, 2024 and November 11, 2026 may seek appointment as lead plaintiff by January 19, 2027. That is a procedural milestone, not a verdict, and...

Continue Reading
Cottage Grove Tests Holiday Demand Across Lake Norman

Updated Category News Views 154

Flour and foot traffic make a pretty honest little scoreboard. Cottage Grove Bakery is putting itself in front of Lake Norman shoppers twice on Saturday, November 21, while also taking Thanksgiving orders and laying groundwork for 2027 workplace and school visits. This is not a public-company earnings story, and nobody should pretend a tray of scones is a quarterly...

Continue Reading
Fractional CIOs Bring Order to Growing Technology Chaos

Updated Category News Views 71

A company can outgrow its technology habits long before anyone notices the smoke. One day the owner is approving another software subscription, the office manager is chasing an internet provider, and the tech person is putting out password fires. None of that looks dramatic in isolation. Together, it is a business operating without a map. That is the useful point in the...

Continue Reading
Fluence Investors Face a November 27 Litigation Clock

Updated Category News Views 157

Six calendar squares are all that separate eligible Fluence investors from the November 27, 2026 lead-plaintiff deadline. That is not much time to locate trade confirmations, calculate losses, and decide whether taking a larger role in a securities case makes sense. The lawsuit is not a verdict, and anybody pretending otherwise is selling smoke. But the underlying...

Continue Reading
Epic Blue Puts $50,000 of Marketing Work to Use Locally

Updated Category News Views 136

A $50,000 pile of donated know-how can look soft on a spreadsheet, until you remember how often a small nonprofit or early-stage outfit gets ignored because it cannot afford someone to sharpen its message. Epic Blue Marketing, a women-owned firm based in Jackson, Michigan, says it provided that amount in donated and reduced-rate marketing, communications and public...

Continue Reading
3TREES Tests a Bigger Asia-Pacific Growth Blueprint

Updated Category News Views 154

A bucket of paint rarely sounds strategic until it sits inside a regional supply chain. That is the useful part of 3TREES chairman and president Hong Jie's message from the Asia-Pacific Economic Cooperation CEO Summit in Shenzhen on November 17-18, 2026: coatings are not merely a commodity if the supplier can bring materials, energy savings, technical know-how and...

Continue Reading
UAE Trust Model Faces Its Hardest Test During Crisis

Updated Category News Views 27

A country’s reputation is usually invisible right up until the machinery rattles. Then people, investors, trading partners and residents stop listening to polished slogans and start watching whether airports function, services hold up, information arrives, and business can keep moving. That was the useful core of Saeed Al Eter’s remarks at Ajman Media Forum 2026: soft...

Continue Reading
Kyverna Probe Reopens IPO Disclosure Questions for Investors

Updated Category News Views 93

Clinical-trial caveats have a nasty habit of becoming shareholder headaches years later. Kyverna Therapeutics is back in that uncomfortable zone after Kahn Swick & Foti said it has opened an investigation into whether the company’s officers and directors breached fiduciary duties or otherwise violated state or federal law. For holders of KYTX, this is not a verdict and...

Continue Reading
Sitting, Lymph Flow, and a Supplement Maker's Pitch

Updated Category News Views 129

By late afternoon, a chair can feel like it has quietly won the argument against your legs. PureHealth Research is leaning into that familiar heavy, puffy-legged feeling with a reminder about lymphatic flow—and, naturally, an eight-ingredient supplement positioned alongside it. The broad message is sensible. The sales layer needs the usual healthy squint. Movement Does...

Continue Reading
Maryland Handgun Ban Suit Puts Ruger in Legal Crossfire

Updated Category News Views 150

A January Deadline With Real Commercial Teeth Maryland has turned a trigger-design dispute into a fresh legal and retail headache, and the clock is not polite about it. The National Shooting Sports Foundation filed suit against the state over S.B. 334, which is scheduled to take effect Jan. 1, 2027. The law bars sales of certain pistols with cruciform trigger bars,...

Continue Reading

Top 5 Most Recently Viewed Articles

Coca-Cola's Emerging Markets Strategy Fuels Long-Term Growth

Updated Category News Views 929

Coca-Cola's Position in Emerging Markets Coca-Cola Co (NYSE: KO) stands as a beacon of growth, with a visionary strategy that highlights both immediate and long-term opportunities. The company has successfully positioned itself in vital markets, particularly in North America and Latin America, which have proven central to its success. According to recent insights from...

Continue Reading
Voda IQ Appoints Armando Piccinini to Drive European Sales

Updated Category News Views 121

Voda IQ dropped some big news back in 2024 when they appointed Armando Piccinini as their European Sales Director. This guy’s got over twenty years under his belt in aquatic conservation, which they clearly hope will ramp up their sales strategy across Europe. But you gotta wonder—are the numbers behind this move really there? Can Experience Translate to Sales Growth?...

Continue Reading
Magnera Corporation to Shine at Upcoming Finance Conference

Updated Category News Views 163

Magnera Corporation's Conference Participation Announcement Magnera Corporation (NYSE: MAGN) has made an exciting announcement regarding its upcoming participation in a significant financial event. The company is set to be a part of the 2025 Bank of America Leveraged Finance Conference, aimed at fostering connections with top institutional investors. The event will take...

Continue Reading
Bullish Momentum Unveiled: Insights on Merck & Co Stocks

Updated Category News Views 180

Exciting Developments in Merck & Co Options Activity Notable investors are expressing strong optimism about Merck & Co. A recent analysis of options trading strategies reveals a wave of activity among traders aiming to capitalize on this potential. Options Trading Overview When reviewing the options history for Merck & Co (NYSE: MRK), we found a total of 33 trades that...

Continue Reading
Gilead Snags Arcellx: A High-Stakes Cancer Gamble Unfolds

Updated Category News Views 195

The Big Play for Cancer Innovation Gilead Sciences Inc. (NASDAQ:GILD) pulled the trigger on a pretty huge acquisition deal, landing Arcellx Inc. (NASDAQ:ACLX) this past Monday for a staggering $115 per share, which gets better with a potential extra $5 per share on a contingent value right. That rings in a hefty total of $7.8 billion—no pocket change, folks. What’s...

Continue Reading